TORONTO–(BUSINESS WIRE)–Today, NEO welcomes its newest corporate listing partner, Biomind Labs Inc. (Biomind), as it makes its public markets debut on the NEO Exchange. A biotechnology research and development company specializing in psychedelic treatments…

Click here to view the original article.